Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62.5M
-
Number of holders
-
216
-
Total 13F shares, excl. options
-
50.7M
-
Shares change
-
-860K
-
Total reported value, excl. options
-
$4.06B
-
Value change
-
-$62.5M
-
Put/Call ratio
-
1.49
-
Number of buys
-
97
-
Number of sells
-
-97
-
Price
-
$80.11
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q4 2019
262 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q4 2019.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 216 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.7M shares
of 62.5M outstanding shares and own 81.07% of the company stock.
Largest 10 shareholders include FMR LLC (7.38M shares), VANGUARD GROUP INC (4.37M shares), BlackRock Inc. (4.26M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.35M shares), WELLINGTON MANAGEMENT GROUP LLP (2.47M shares), CADIAN CAPITAL MANAGEMENT, LP (1.97M shares), STATE STREET CORP (1.87M shares), Invesco Ltd. (1.54M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (1.5M shares), and VIKING GLOBAL INVESTORS LP (1.31M shares).
This table shows the top 216 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.